Bionano Genomics, Inc. (BNGO)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostic Kits / Equipment	28.51M	30.78M	36.12M	27.80M	17.98M
Total	28.51M	30.78M	36.12M	27.80M	17.98M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	4.51M	4.91M	7.93M	5.82M	4.29M
Americas (excl. United States)	7.67M	8.74M	10.09M	8.04M	5.04M
Europe, The Middle East and Africa (EMEA)	14.11M	14.23M	12.96M	8.96M	5.60M
Asia Pacific	2.22M	2.89M	-	-	-
Asia Pacific (Excluding China)	-	-	4.62M	4.28M	2.71M
China	-	-	513.30K	697.20K	335.28K
Total	28.51M	30.78M	36.12M	27.80M	17.98M

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error